Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.
01 2Symbiotec Pharmalab
02 1EUROAPI
03 1Bayer AG
04 2Fujifilm Diosynth Biotechnologies
05 1Henan Lihua Pharmaceutical
06 1Laboratorio Syntex S.A
07 2Pfizer Inc
08 1Quimica Sintetica
09 1SIMS Srl
10 2Tianjin Tianyao Pharmaceuticals Co., Ltd.
11 1Zhejiang Xianju Pharmaceutical Co. Ltd
01 1(VET) 6-ALPHA-9-A-DIFLUORO-16-A-METHYL PREDNISOLONE DESIGNATED RS 2177
02 16-ALPHA METHYLPREDNISOLONE
03 16-METHYLPREDNISOLNE
04 16a-METHYLPREDNISOLONE
05 3METHYLPREDNISOLONE
06 1METHYLPREDNISOLONE 100MG TABLETS
07 2METHYLPREDNISOLONE USP
08 1METHYLPREDNISOLONE USP (PROCESS 2)
09 1METHYLPREDNISOLONE USP KALAMAZOO
10 1METHYLPREDNISOLONE USP, NON-STERILE BULK DRUG SUBSTANCE
11 1METHYLPREDNISOLONE, USP
12 1METHYLPREDNISOLONE, USP (MICRONIZED)
01 1Argentina
02 4China
03 1France
04 1Germany
05 2India
06 1Italy
07 1Spain
08 2U.S.A
09 2United Kingdom
01 8Active
02 7Inactive
01 4Complete
02 11Blank
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-21
Pay. Date : 2013-12-17
DMF Number : 27783
Submission : 2013-11-25
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-01
Pay. Date : 2013-12-10
DMF Number : 3771
Submission : 1980-04-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34637
Submission : 2020-11-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3592
Submission : 1979-08-06
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31630
Submission : 2017-04-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 601
Submission : 1963-06-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4796
Submission : 1983-01-06
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-05
Pay. Date : 2013-09-16
DMF Number : 26458
Submission : 2012-09-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17547
Submission : 2004-07-19
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-02
Pay. Date : 2020-02-26
DMF Number : 25067
Submission : 2011-06-18
Status : Active
Type : II
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one, including repackagers and relabelers. The FDA regulates (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one supplier is an individual or a company that provides (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one active pharmaceutical ingredient (API) or (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one finished formulations upon request. The (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers may include (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one API manufacturers, exporters, distributors and traders.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one DMF (Drug Master File) is a document detailing the whole manufacturing process of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one active pharmaceutical ingredient (API) in detail. Different forms of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one DMFs exist exist since differing nations have different regulations, such as (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one DMF submitted to regulatory agencies in the US is known as a USDMF. (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one USDMF includes data on (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one suppliers with USDMF on PharmaCompass.
We have 11 companies offering (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?